AstraZeneca (AZN) Denies Rumors About UK Facility Relocation

Per an article by Seeking Alpha (“SA”), AstraZeneca (AZN) dismissed a media report that claimed it may shift its vaccine manufacturing site from the U.K. to the United States.This reported denial comes in response to last week's article by the Financial Times (“FT”), which claimed that discussions between AstraZeneca and the U.K. government concerning state aid had hit an impasse. This report, which cited multiple unknown sources, claimed that chancellor Rachel Reeves was looking to reduce the amount of sta ...